The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMedium•17 April 2026•

1 min read

Walmart Expands Healthcare Services to Support GLP-1 Weight-Loss Drug Users

Man in suit before Walmart dashboards, e-commerce charts, and ad data. Golden growth arrows, shopping carts, and kiosks.

Key Facts

1Walmart expanded its Better Care Services platform to include virtual care and nutrition services for customers using or exploring GLP-1 medications.

Walmart has announced the expansion of its Better Care Services platform to include virtual care and tailored nutrition services for customers using GLP-1 medications. The platform connects users with third-party healthcare providers, integrating these services with Walmart’s existing pharmacy and delivery infrastructure. This strategic move aims to capitalize on the surging demand for weight-loss treatments like Ozempic and Wegovy by providing a holistic support system. By offering specialized care, Walmart seeks to drive increased traffic to both its pharmacy and grocery segments. Analysts view this expansion as a bullish signal for WMT, as it strengthens customer loyalty and diversifies revenue streams within the high-growth healthcare sector. The integration of virtual support highlights Walmart's commitment to becoming a comprehensive health and wellness destination.